Monsanto Sees Tremendous Progress In R&D Pipeline

Roundup RReady2Yield Soybean Project Moves To Pre-Launch Phase, One Step Closer To Commercialization

08-Jan-2007

Monsanto Company reported on a remarkable year in research-and-development (R&D) advancements, highlighting progress across both its biotechnology and breeding platforms. The company's announcement came as part of its first-quarter 2007 fiscal year conference call.

Monsanto reported on seven specific projects in the research-and-development pipeline that either advanced from one phase to the next or were added to the pipeline. The update also highlighted the company's three High Impact Technology (HIT) projects.

"In the last two years, there has been positive movement in 70 percent of the projects in the pipeline," said Robert T. Fraley, Ph.D., chief technology officer and executive vice president for Monsanto. "Of that advancement, almost half are from additions to the pipeline, reflecting the strength of our discovery engine and our collaborative efforts."

Parliamentary State Secretary Thomas Rachel (right) handed over the funding notification to Georg Schaumann (left) from SenseUp and Prof. Dr. Jörn Kalinowski (centre) from CeBiTec.

Low-cost production of RNA-based vaccines and active substances

Cost-effective and flexible production systems for RNA-based active ingredients

Read news

The presentation outlined several key measures of progress including the three HIT projects:

* Roundup RReady2Yield soybeans, the company's next-generation, herbicide-tolerant technology in soybeans, moved to Phase 4. The movement, which was based on results from its 2006 breeding trials, advanced the technology one step closer to commercial launch.

* Vistive III soybeans, designed to have a similar oil profile to olive oil, met the company's target composition profile on three of its genetic events.

* First-generation Drought Tolerant corn continued to demonstrate yield benefits in its third year of field testing.

Fraley's presentation was focused on the combined benefits of biotechnology and breeding, emphasizing the fact that both platforms drive plant science innovation. "As excited as we are about the biotech pipeline, we understand that our success rides on the combination of biotechnology and breeding," Fraley said. "We've put a lot of emphasis on making sure that - before we ever look to biotechnology - we have the best, highest yielding seed possible so farmers can start each season strong."

https://www.bionity.com/en/news/60569/monsanto-sees-tremendous-progress-in-r-d-pipeline.html